In addition, NF-κB gene expression is often associated with genetic or epigenetic alterations, indicating a possible role of these processes in the pathogenic effects of the pro-inflammatory signaling pathway in myeloma. The gene discussed is NFKB1; the disease is plasma cell myeloma.